Cargando…
Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Therefore, the development of diagnostic biomarkers for PDAC are urgently needed to improve patient stratification and outcome in the clinic. By studying the...
Autores principales: | Klett, Hagen, Fuellgraf, Hannah, Levit-Zerdoun, Ella, Hussung, Saskia, Kowar, Silke, Küsters, Simon, Bronsert, Peter, Werner, Martin, Wittel, Uwe, Fritsch, Ralph, Busch, Hauke, Boerries, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895731/ https://www.ncbi.nlm.nih.gov/pubmed/29675033 http://dx.doi.org/10.3389/fgene.2018.00108 |
Ejemplares similares
-
Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts
por: Corrales, Eyleen, et al.
Publicado: (2021) -
PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
por: Corrales, Eyleen, et al.
Publicado: (2022) -
Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
por: Braun, Lukas M., et al.
Publicado: (2020) -
Boolean approach to signalling pathway modelling in HGF-induced keratinocyte migration
por: Singh, Amit, et al.
Publicado: (2012) -
Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)